FDA
-
-
-
-
-
-
-
Soleno Therapeutics names Jennifer Fulk as CFO, James Mackaness to retire
-
-
-
-
-
-
-
Soleno Therapeutics Announces Publication of Results from Pivotal Study of VYKAT⢠XR in the Journal of Clinical Endocrinology and Metabolism
-
-
-
-
-
-
-
Soleno Therapeutics Appoints Biopharmaceutical Executive Mark W. Hahn to its Board of Directors
-
-
-
-
-
-
-
Soleno Therapeutics prices $200 million stock offering at $85 per share
-
-
-
-
-
-
-
Soleno Therapeutics Announces Multiple Presentations at the 2025 United in Hope: International Prader-Willi Syndrome Conference
-
-
-
-
-
-
-
Soleno Therapeutics Announces Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at ISPOR 2025
-
-
-
-
-
-
-
Soleno Therapeutics Inc. (SLNO) PT Raised to $100 at H.C. Wainwright
-
323,009 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

